Prevent.net   SUBMIT


  close
Interested in buying this domain?
A Japanese government panel approved Novartis' cancer treatment Kymriah at a price of 33.5 million yen ($305,800) on Wednesday, marking the entry of so-called CAR-T therapy in the country.